lumykras
amgen europe bv - sotorasib - karcinoma, nesmulkiųjų ląstelių skausmas - antinavikiniai vaistai - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.
orserdu
stemline therapeutics b.v. - elacestrant - krūties navikai - endokrininė terapija - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
crinone
merck serono sia - progesteronas - makšties gelis - 80 mg/g - progesterone
crinone
limedika, uab - progesteronas - makšties gelis - 80 mg/g - progesterone
crinone
ideal trade links, uab - progesteronas - makšties gelis - 80 mg/g - progesterone